Crosstalk between the lung microbiome and lung cancer

Area of Science:

• Microbiology
• Pulmonology
• Oncology

Background:

• The human body, including the lungs, hosts a complex microbiome.
• The lung microbiome, once considered sterile, is now recognized and linked to various lung diseases.
• Dysbiosis and reduced microbial diversity in the lungs are associated with conditions such as COPD, asthma, and lung cancer.

Purpose of the Study:

• To review the correlation between lung microbiota and lung cancer.
• To investigate the mechanisms by which lung microorganisms influence lung cancer development.
• To explore potential future diagnostic and therapeutic applications based on lung microbiota research.

Main Methods:

• Literature review of current studies on pulmonary microbiome and lung cancer.
• Analysis of existing research on the role of lung microbiota in disease pathogenesis.
• Synthesis of findings regarding microbial influence on host immune system in cancer.

Main Results:

• The lung microbiome is associated with lung diseases, including cancer.
• Microbial dysbiosis in the lungs can affect cancer occurrence and progression.
• Microorganisms can indirectly promote cancer growth via the host immune system.

Conclusions:

• The lung microbiome plays a significant role in lung cancer.
• Further research into lung microbiota mechanisms can lead to novel diagnostic and therapeutic strategies for lung cancer.
• Understanding the lung microbiota offers new avenues for treating and diagnosing lung cancer.